Opinion | 'We Should Follow That Signal': What We Heard This Week

— Quotable quotes heard by MedPage Today's reporters

August 2, 2026

• 2 min read

"There is some signal there and we should follow that signal." -- John Carrino, MD, MPH, of Weill Cornell Medicine in New York City, in an FDA advisory committee meeting that supported RP1 (vusolimogene oderparepvec), a twice-rejected melanoma drug.

"This showed us there is nothing stable." -- Konstantin Dragnev, MD, of Dartmouth Cancer Center in New Hampshire, on slowing federal support for National Cancer Institute-designated cancer centers.